Phase III Study to Assess the Long Term Efficacy, Carry-over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets
Clinical trial NCT00418379 · COMPLETED
Trial details
- NCT number
- NCT00418379
- Sponsor
- Stallergenes Greer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2010-08-01
- Enrollment
- 633
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.